Analystreport

CVS Health (NYSE:CVS) had its price target lowered by analysts at Argus from $91.00 to $90.00. They now have a "buy" rating on the stock.

CVS Health Corporation  (CVS) 
Last cvs health corporation earnings: 2/12 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.cvshealth.com